| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8457568 | Nuclear Medicine and Biology | 2018 | 10 Pages |
Abstract
The striking similar in vivo behavior of [18F]3-d7 to that of (R)-[11C]verapamil, and its improved metabolic stability compared with the other fluorine-18 labeled tracers synthesized, supports the potential clinical translation of [18F]3-d7 as a PET radiopharmaceutical for P-gp evaluation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Renske M. Raaphorst, Gert Luurtsema, Cindy J. Schokker, Khaled A. Attia, Robert C. Schuit, Philip H. Elsinga, Adriaan A. Lammertsma, Albert D. Windhorst,